Compliance Rate
Compliance Rate
42.86%
Compliant submissions
3
Incompliant submissions
4
Total trials
7
My Organizations' Clinical Trials
Showing 1600 of 2008 entries
View as:
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/04/21
End: 12/01/29
Due: 12/01/30
Phase: N/A
Priority: Normal
Start: 11/02/22
End: 05/04/25
Due: 05/04/26
Phase: N/A
Priority: Normal
Start: 08/06/20
End: 03/01/26
Due: 03/01/27
Phase: N/A
Priority: Normal
Start: 07/24/18
End: 11/06/23
Due: 11/06/24
Phase: N/A
Priority: Normal
Start: 03/06/20
End: 07/31/21
Due: 07/31/22
Phase: N/A
Priority: Normal
Start: 11/30/02
End: 10/31/07
Due: 10/31/08
Phase: N/A
Priority: Normal
Start: 10/15/20
End: 10/17/24
Due: 10/17/25
Phase: N/A
Priority: Normal
Start: 12/31/25
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 06/30/05
End: 02/29/12
Due: 02/28/13
Phase: N/A
Priority: Normal
Start: 10/31/08
End: 08/31/11
Due: 08/31/12
Phase: N/A
Priority: Normal
Start: 05/31/03
End: 10/31/07
Due: 10/31/08
Phase: N/A
Priority: Normal
Start: 07/12/19
End: 03/03/24
Due: 03/03/25
Phase: N/A
Priority: Normal
Start: 08/01/18
End: 12/31/28
Due: 12/31/29
Phase: N/A
Priority: Normal
Start: 08/31/06
End: 04/30/10
Due: 04/30/11
Phase: N/A
Priority: Normal
Start: 08/31/14
End: 12/17/21
Due: 12/17/22
Phase: N/A
Priority: Normal
Start: 08/01/25
End: 07/31/26
Due: 07/31/27
DTPA (Diethylenetriaminepenta-acetate) Chelation for Symptoms After Gadolinium-assisted MRI Exposure
Phase: N/A
Priority: Normal
Start: 04/11/23
End: 09/13/24
Due: 09/13/25
Phase: N/A
Priority: Normal
Start: 07/23/19
End: 03/28/22
Due: 03/28/23
Phase: N/A
Priority: Normal
Start: 05/31/10
End: 07/31/16
Due: 07/31/17
Phase: N/A
Priority: Normal
Start: 06/01/26
End: 05/31/27
Due: 05/31/28
Phase: N/A
Priority: Normal
Start: 05/23/22
End: 10/31/26
Due: 10/31/27
Phase: N/A
Priority: Normal
Start: 10/01/25
End: 09/30/27
Due: 09/30/28
Phase: N/A
Priority: Normal
Start: 04/30/10
End: 08/31/12
Due: 08/31/13
Phase: N/A
Priority: Normal
Start: 04/04/22
End: 04/03/23
Due: 04/03/24